↓ Skip to main content

Dove Medical Press

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news
1 news outlet
twitter
5 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
23 Mendeley
Title
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
Published in
ClinicoEconomics and Outcomes Research: CEOR, September 2018
DOI 10.2147/ceor.s168298
Pubmed ID
Authors

Lee S Schwartzberg, Lincy S Lal, Sanjeev Balu, Kim Campbell, Lee Brekke, Caitlin Elliott, Stephanie Korrer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 17%
Student > Master 4 17%
Student > Doctoral Student 3 13%
Student > Bachelor 2 9%
Lecturer 1 4%
Other 2 9%
Unknown 7 30%
Readers by discipline Count As %
Medicine and Dentistry 6 26%
Pharmacology, Toxicology and Pharmaceutical Science 5 22%
Biochemistry, Genetics and Molecular Biology 2 9%
Nursing and Health Professions 1 4%
Computer Science 1 4%
Other 1 4%
Unknown 7 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2018.
All research outputs
#2,979,539
of 25,461,852 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#62
of 525 outputs
Outputs of similar age
#57,473
of 345,970 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#4
of 14 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,970 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.